Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.53B |
| 3 |
Amazon
AMZN
|
+$1.11B |
| 4 |
Airbnb
ABNB
|
+$574M |
| 5 |
NVIDIA
NVDA
|
+$519M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$588M |
| 2 |
NIO
NIO
|
+$539M |
| 3 |
Apple
AAPL
|
+$525M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$443M |
| 5 |
Microsoft
MSFT
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.77% |
| 2 | Consumer Discretionary | 1.94% |
| 3 | Technology | 1.9% |
| 4 | Communication Services | 1.42% |
| 5 | Financials | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
CALL
MasTec
MTZ
$20.2B
| $9.89M | ﹤0.01% |
93,200
+44,700
| +92% | +$4.85M |
|
2877
Kulicke & Soffa
KLIC
$4.43B
| $9.88M | ﹤0.01% |
161,382
+152,912
| +1,805% | +$8.23M |
|
2878
CALL
SM Energy
SM
$8.76B
| $9.87M | ﹤0.01% |
400,900
-909,900
| -69% | -$17.6M |
|
|
SIX
2879
DELISTED
Six Flags Entertainment Corp.
SIX
| $9.85M | ﹤0.01% |
227,627
+181,217
| +390% | +$8.17M |
|
2880
CALL
Revvity
RVTY
$14.5B
| $9.84M | ﹤0.01% |
63,700
+27,800
| +77% | +$3.91M |
|
2881
Weyerhaeuser
WY
$17.1B
| $9.83M | ﹤0.01% |
285,523
-142,622
| -33% | -$5.29M |
|
2882
PUT
Hormel Foods
HRL
$11.7B
| $9.83M | ﹤0.01% |
205,800
+91,400
| +80% | +$4.35M |
|
|
AJRD
2883
PUT
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $9.82M | ﹤0.01% |
203,400
-8,300
| -4% | -$399K |
|
2884
PUT
GATX Corp
GATX
$6.3B
| $9.82M | ﹤0.01% |
111,000
+108,400
| +4,169% | +$10.4M |
|
2885
Ultragenyx Pharmaceutical
RARE
$2.59B
| $9.81M | ﹤0.01% |
102,917
+93,594
| +1,004% | +$9.75M |
|
2886
Cognizant
CTSH
$28.7B
| $9.81M | ﹤0.01% |
141,604
+49,367
| +54% | +$3.68M |
|
2887
Welltower
WELL
$173B
| $9.8M | ﹤0.01% |
117,974
-18,931
| -14% | -$1.45M |
|
2888
CALL
Antero Midstream
AM
$10.7B
| $9.8M | ﹤0.01% |
943,300
+143,400
| +18% | +$1.37M |
|
2889
CALL
Quince Therapeutics
QNCX
$33.1M
| $9.8M | ﹤0.01% |
925
+481
| +108% | +$4.03M |
|
2890
CALL
Molina Healthcare
MOH
$10.4B
| $9.79M | ﹤0.01% |
38,700
-1,800
| -4% | -$452K |
|
2891
Molson Coors Class B
TAP
$7.77B
| $9.79M | ﹤0.01% |
182,335
+34,883
| +24% | +$1.95M |
|
2892
CALL
ProShares Ultra Technology
ROM
$1.29B
| $9.78M | ﹤0.01% |
203,200
+124,000
| +157% | +$5.27M |
|
2893
CALL
MarketAxess Holdings
MKTX
$5.72B
| $9.78M | ﹤0.01% |
21,100
-5,400
| -20% | -$2.57M |
|
2894
CALL
Willis Towers Watson
WTW
$31.5B
| $9.78M | ﹤0.01% |
42,500
+24,800
| +140% | +$6.17M |
|
2895
PUT
Ascendis Pharma A/S
ASND
$16.4B
| $9.77M | ﹤0.01% |
74,300
+27,400
| +58% | +$3.65M |
|
|
VTNR
2896
DELISTED
Vertex Energy, Inc
VTNR
| $9.76M | ﹤0.01% |
737,648
+591,521
| +405% | +$2.45M |
|
|
VTLE
2897
DELISTED
Vital Energy
VTLE
| $9.76M | ﹤0.01% |
105,162
-60,744
| -37% | -$3.13M |
|
2898
CALL
Ameriprise Financial
AMP
$49.1B
| $9.76M | ﹤0.01% |
39,200
+15,100
| +63% | +$3.81M |
|
2899
CALL
Globant
GLOB
$1.73B
| $9.75M | ﹤0.01% |
44,500
+29,700
| +201% | +$6.53M |
|
2900
PUT
Mattel
MAT
$4.26B
| $9.74M | ﹤0.01% |
484,700
-528,500
| -52% | -$10.9M |
|
Similar funds
Jeff Yass's Q2 2021 Portfolio in Review
As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 91% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
- Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
- Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
- Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
- Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
- Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
- Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.
Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.